PROCESSES FOR THE PREPARATION OF 4- 4- 4-(2 -CYANOETHENYL)-2,6-DIMETHYLPHENYL )AMINO) -2-PYRIMIDINYL)AMINO BENZONITRILE
Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile of formula (I), a N-oxide, a pharmaceutically acceptable acid addition salt, a quaternary amine or a stereochemically isomeric form thereof are provided, said processes comprise: a...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; slv |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | GUILLEMONT JEROME E.G. JOHNSON & JOHNSON PHARM SCHILS DIDIER P. R. JANSSEN PHARMACEUTICA N.V HEERES JAN JANSSEN PHARMACEUTICA N.V MEDAER B. P. A. M. J. JANSSEN PHARMACEUTICA N.V PASQUIER E. T. J. JOHNSON & JOHNSON PHARMACEUTICAL R.&D JANSSEN PAUL ADRIAAN JAN WILLEMS JOANNES J. M. JANSSEN PHARMACEUTICA N.V LEENDERS RUBEN GERARDUS GEORGE MERCA |
description | Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile of formula (I), a N-oxide, a pharmaceutically acceptable acid addition salt, a quaternary amine or a stereochemically isomeric form thereof are provided, said processes comprise: a) reacting 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine with an intermediate of formula (III) in the presence of a suitable solvent; b) reacting an intermediate of formula (IV) with acrylonitrile in the presence of a suitable palladium catalyst, a suitable base and a suitable solvent; c) dehydrating the corresponding amide of the compound of formula (I). |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI1529032TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI1529032TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI1529032TT13</originalsourceid><addsrcrecordid>eNqNirEKwjAURbs4iPoPz82CAZtWwTG2r_RBm4QkS1xKkTiJFir4-9bqBwgXDvdw5tFLG5WjtWihVAZchaANamGEIyVBlZCx7zYcWO6FVDhG0tcx49sDK6gZv6_15CAWDUkVA-NMe0MNFfRJJwsnlGclyRmqcRnNrt1tCKsfF9G6RJdXLPSPNgx9dwn38GwtJXt-3KXcuST9p3kDlxY46w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PROCESSES FOR THE PREPARATION OF 4- 4- 4-(2 -CYANOETHENYL)-2,6-DIMETHYLPHENYL )AMINO) -2-PYRIMIDINYL)AMINO BENZONITRILE</title><source>esp@cenet</source><creator>GUILLEMONT JEROME E.G. JOHNSON & JOHNSON PHARM ; SCHILS DIDIER P. R. JANSSEN PHARMACEUTICA N.V ; HEERES JAN JANSSEN PHARMACEUTICA N.V ; MEDAER B. P. A. M. J. JANSSEN PHARMACEUTICA N.V ; PASQUIER E. T. J. JOHNSON & JOHNSON PHARMACEUTICAL R.&D ; JANSSEN PAUL ADRIAAN JAN ; WILLEMS JOANNES J. M. JANSSEN PHARMACEUTICA N.V ; LEENDERS RUBEN GERARDUS GEORGE MERCA</creator><creatorcontrib>GUILLEMONT JEROME E.G. JOHNSON & JOHNSON PHARM ; SCHILS DIDIER P. R. JANSSEN PHARMACEUTICA N.V ; HEERES JAN JANSSEN PHARMACEUTICA N.V ; MEDAER B. P. A. M. J. JANSSEN PHARMACEUTICA N.V ; PASQUIER E. T. J. JOHNSON & JOHNSON PHARMACEUTICAL R.&D ; JANSSEN PAUL ADRIAAN JAN ; WILLEMS JOANNES J. M. JANSSEN PHARMACEUTICA N.V ; LEENDERS RUBEN GERARDUS GEORGE MERCA</creatorcontrib><description>Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile of formula (I), a N-oxide, a pharmaceutically acceptable acid addition salt, a quaternary amine or a stereochemically isomeric form thereof are provided, said processes comprise: a) reacting 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine with an intermediate of formula (III) in the presence of a suitable solvent; b) reacting an intermediate of formula (IV) with acrylonitrile in the presence of a suitable palladium catalyst, a suitable base and a suitable solvent; c) dehydrating the corresponding amide of the compound of formula (I).</description><language>eng ; slv</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; APPARATUS THEREFOR ; CHEMISTRY ; GENERAL METHODS OF ORGANIC CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130830&DB=EPODOC&CC=SI&NR=1529032T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130830&DB=EPODOC&CC=SI&NR=1529032T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GUILLEMONT JEROME E.G. JOHNSON & JOHNSON PHARM</creatorcontrib><creatorcontrib>SCHILS DIDIER P. R. JANSSEN PHARMACEUTICA N.V</creatorcontrib><creatorcontrib>HEERES JAN JANSSEN PHARMACEUTICA N.V</creatorcontrib><creatorcontrib>MEDAER B. P. A. M. J. JANSSEN PHARMACEUTICA N.V</creatorcontrib><creatorcontrib>PASQUIER E. T. J. JOHNSON & JOHNSON PHARMACEUTICAL R.&D</creatorcontrib><creatorcontrib>JANSSEN PAUL ADRIAAN JAN</creatorcontrib><creatorcontrib>WILLEMS JOANNES J. M. JANSSEN PHARMACEUTICA N.V</creatorcontrib><creatorcontrib>LEENDERS RUBEN GERARDUS GEORGE MERCA</creatorcontrib><title>PROCESSES FOR THE PREPARATION OF 4- 4- 4-(2 -CYANOETHENYL)-2,6-DIMETHYLPHENYL )AMINO) -2-PYRIMIDINYL)AMINO BENZONITRILE</title><description>Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile of formula (I), a N-oxide, a pharmaceutically acceptable acid addition salt, a quaternary amine or a stereochemically isomeric form thereof are provided, said processes comprise: a) reacting 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine with an intermediate of formula (III) in the presence of a suitable solvent; b) reacting an intermediate of formula (IV) with acrylonitrile in the presence of a suitable palladium catalyst, a suitable base and a suitable solvent; c) dehydrating the corresponding amide of the compound of formula (I).</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>APPARATUS THEREFOR</subject><subject>CHEMISTRY</subject><subject>GENERAL METHODS OF ORGANIC CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNirEKwjAURbs4iPoPz82CAZtWwTG2r_RBm4QkS1xKkTiJFir4-9bqBwgXDvdw5tFLG5WjtWihVAZchaANamGEIyVBlZCx7zYcWO6FVDhG0tcx49sDK6gZv6_15CAWDUkVA-NMe0MNFfRJJwsnlGclyRmqcRnNrt1tCKsfF9G6RJdXLPSPNgx9dwn38GwtJXt-3KXcuST9p3kDlxY46w</recordid><startdate>20130830</startdate><enddate>20130830</enddate><creator>GUILLEMONT JEROME E.G. JOHNSON & JOHNSON PHARM</creator><creator>SCHILS DIDIER P. R. JANSSEN PHARMACEUTICA N.V</creator><creator>HEERES JAN JANSSEN PHARMACEUTICA N.V</creator><creator>MEDAER B. P. A. M. J. JANSSEN PHARMACEUTICA N.V</creator><creator>PASQUIER E. T. J. JOHNSON & JOHNSON PHARMACEUTICAL R.&D</creator><creator>JANSSEN PAUL ADRIAAN JAN</creator><creator>WILLEMS JOANNES J. M. JANSSEN PHARMACEUTICA N.V</creator><creator>LEENDERS RUBEN GERARDUS GEORGE MERCA</creator><scope>EVB</scope></search><sort><creationdate>20130830</creationdate><title>PROCESSES FOR THE PREPARATION OF 4- 4- 4-(2 -CYANOETHENYL)-2,6-DIMETHYLPHENYL )AMINO) -2-PYRIMIDINYL)AMINO BENZONITRILE</title><author>GUILLEMONT JEROME E.G. JOHNSON & JOHNSON PHARM ; SCHILS DIDIER P. R. JANSSEN PHARMACEUTICA N.V ; HEERES JAN JANSSEN PHARMACEUTICA N.V ; MEDAER B. P. A. M. J. JANSSEN PHARMACEUTICA N.V ; PASQUIER E. T. J. JOHNSON & JOHNSON PHARMACEUTICAL R.&D ; JANSSEN PAUL ADRIAAN JAN ; WILLEMS JOANNES J. M. JANSSEN PHARMACEUTICA N.V ; LEENDERS RUBEN GERARDUS GEORGE MERCA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI1529032TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2013</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>APPARATUS THEREFOR</topic><topic>CHEMISTRY</topic><topic>GENERAL METHODS OF ORGANIC CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GUILLEMONT JEROME E.G. JOHNSON & JOHNSON PHARM</creatorcontrib><creatorcontrib>SCHILS DIDIER P. R. JANSSEN PHARMACEUTICA N.V</creatorcontrib><creatorcontrib>HEERES JAN JANSSEN PHARMACEUTICA N.V</creatorcontrib><creatorcontrib>MEDAER B. P. A. M. J. JANSSEN PHARMACEUTICA N.V</creatorcontrib><creatorcontrib>PASQUIER E. T. J. JOHNSON & JOHNSON PHARMACEUTICAL R.&D</creatorcontrib><creatorcontrib>JANSSEN PAUL ADRIAAN JAN</creatorcontrib><creatorcontrib>WILLEMS JOANNES J. M. JANSSEN PHARMACEUTICA N.V</creatorcontrib><creatorcontrib>LEENDERS RUBEN GERARDUS GEORGE MERCA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GUILLEMONT JEROME E.G. JOHNSON & JOHNSON PHARM</au><au>SCHILS DIDIER P. R. JANSSEN PHARMACEUTICA N.V</au><au>HEERES JAN JANSSEN PHARMACEUTICA N.V</au><au>MEDAER B. P. A. M. J. JANSSEN PHARMACEUTICA N.V</au><au>PASQUIER E. T. J. JOHNSON & JOHNSON PHARMACEUTICAL R.&D</au><au>JANSSEN PAUL ADRIAAN JAN</au><au>WILLEMS JOANNES J. M. JANSSEN PHARMACEUTICA N.V</au><au>LEENDERS RUBEN GERARDUS GEORGE MERCA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PROCESSES FOR THE PREPARATION OF 4- 4- 4-(2 -CYANOETHENYL)-2,6-DIMETHYLPHENYL )AMINO) -2-PYRIMIDINYL)AMINO BENZONITRILE</title><date>2013-08-30</date><risdate>2013</risdate><abstract>Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile of formula (I), a N-oxide, a pharmaceutically acceptable acid addition salt, a quaternary amine or a stereochemically isomeric form thereof are provided, said processes comprise: a) reacting 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine with an intermediate of formula (III) in the presence of a suitable solvent; b) reacting an intermediate of formula (IV) with acrylonitrile in the presence of a suitable palladium catalyst, a suitable base and a suitable solvent; c) dehydrating the corresponding amide of the compound of formula (I).</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; slv |
recordid | cdi_epo_espacenet_SI1529032TT1 |
source | esp@cenet |
subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS APPARATUS THEREFOR CHEMISTRY GENERAL METHODS OF ORGANIC CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | PROCESSES FOR THE PREPARATION OF 4- 4- 4-(2 -CYANOETHENYL)-2,6-DIMETHYLPHENYL )AMINO) -2-PYRIMIDINYL)AMINO BENZONITRILE |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T00%3A36%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GUILLEMONT%20JEROME%20E.G.%20JOHNSON%20&%20JOHNSON%20PHARM&rft.date=2013-08-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI1529032TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |